USPTO 2015–2025 USPTO PatentsView US Corporation

INO Therapeutics LLC

USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, INO ranks #26,565 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.

#26,565
of 49,997 US assignees by volume
20th percentile
by Innovation Score (26.3/100)
16.9
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26565 · US Corporation #26,565 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,565/49,997
  • PHOTO-FINISH Inhandplus
  • CPC-NARROW A61M · 5 areas
  • INNOV-THIN 26.3/100
  • CLAIMS-RICH 16.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Inhandplus Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around INO

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows INO's Innovation Score is 26.3/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where INO's grants concentrate

INO Therapeutics LLC is a focused PatentsView assignee: 5 CPC subclasses with 50% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2016. By volume, INO sits between Inhandplus Inc. and Institut Straumann AG.

Who files at INO's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows INO holds 10 patents at rank #26,533, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near INO

By rank, the assignees closest to #26,533 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in INO's primary technology class.

INO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162018 1
USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
INO Therapeutics LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 8 80.0%
2016 1 10.0%
2018 1 10.0%

Where it ranks

Overall rank by patents

#26,565

of 49,997 tracked assignees

Innovation Score

26.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

INO Therapeutics LLC's patent record in context - here's where to go next.

  • INO Therapeutics LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 50% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #26,565 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare INO Therapeutics LLC against Inhandplus Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.